What matters, however, is what management can forecast with confidence and what it cannot
Mounjaro (also tirzepatide) holds a separate MHRA authorisation for the treatment of type 2 diabetes [23] [24] Patients should note that Mounjaro and Zepbound contain the same active ingredient (tirzepatide) but are authorised for different indications
SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists Consortium
In the Phase 2 obesity trial, heart-rate increases were dose-dependent, peaked around 24 weeks and then declined afterwards
Early integration of chemistry, manufacturing, and controls considerations into translational planning is therefore essential to avoid late-stage attrition
Patients interested in the Phase 3 programme should check ClinicalTrials.gov or the EU Clinical Trials Register for current trial identifiers, eligibility criteria, and participating sites, as the programme name and trial details should be verified against these authoritative registers
